NEW YORK, July 24, 2015 /PRNewswire/ --
Equity Research Institute has initiated coverage on the
following equities: Ambev S.A. (NYSE: ABEV), Molson Coors Brewing
Company (NYSE: TAP), Anheuser-Busch InBev S.A. (NYSE: BUD),
Constellation Brands Inc. (NYSE: STZ), and Diageo PLC (NYSE: DEO).
Free research report on Ambev can be accessed at
https://www.EquityResearchInstitute.com/reports?keyword=ABEV On
Thursday, July 23, 2015, the NASDAQ
Composite ended at 5,146.41, down 0.49%, the Dow Jones Industrial
Average declined 0.67%, to finish the day at 17,731.92, and the
S&P 500 closed at 2,102.15, down 0.57%. The losses were broad
based as eight out of nine sectors ended the session in negative.
Register for your complimentary reports at the links given below.
On Thursday, shares in Ambev S.A. recorded a trading volume of
11.90 million shares, lower than their three months average volume
of 12.78 million shares. The stock ended the day 3.33% lower at
$5.81. Shares of the company traded
at a PE ratio of 24.21. Ambev S.A.'s stock has lost 5.53% in the
last one month, 8.21% in the previous three months and 6.59% on YTD
basis. The company is trading below its 50-day and 200-day moving
averages by 4.48% and 6.64%, respectively. Furthermore, shares of
Ambev S.A. have a Relative Strength Index (RSI) of 36.04. Sign up
and read the free notes on ABEV at:
https://www.EquityResearchInstitute.com/reports?keyword=ABEV
Molson Coors Brewing Co.'s stock edged 0.76% lower, to close
Thursday's session at $70.82. The
stock recorded a trading volume of 0.79 million shares, below its
three months average volume of 1.50 million shares. Over the last
one month and the previous three months, Molson Coors Brewing Co.'s
shares have fallen by 1.95% and 5.20%, respectively. Additionally,
the stock has lost 3.92% since the start of this year. The company
is trading 2.48% and 4.02% below its 50-day and 200-day moving
averages, respectively. Furthermore, Molson Coors Brewing Co.'s
stock traded at a PE ratio of 30.93 and has an RSI of 44.01. The
complimentary notes on TAP can be downloaded in PDF format at:
https://www.EquityResearchInstitute.com/reports?keyword=TAP
Anheuser-Busch InBev S.A.'s stock finished Thursday's session
1.31% lower at $125.80. A total of
1.41 million shares were traded, which was above its three months
average volume of 1.34 million shares. Over the previous three
months and since the beginning of 2015, Anheuser-Busch InBev S.A.'s
shares have gained 4.52% and 13.99%, respectively. However, the
stock has edged 0.29% lower in the last one month. The company's
shares are trading above their 50-day and 200-day moving averages
by 2.18% and 7.43%, respectively. Anheuser-Busch InBev S.A.'s stock
traded at a PE ratio of 22.75 and has an RSI of 54.00. Register for
free on Equity Research Institute and access the latest research on
BUD at:
https://www.EquityResearchInstitute.com/reports?keyword=BUD
On Thursday, shares in Constellation Brands Inc. ended the
session 1.52% lower at $117.56. The
stock reported a trading volume of 0.64 million shares, below its
three months average volume of 0.96 million shares. Shares of the
company traded at a PE ratio of 29.61. Although, Constellation
Brands Inc.'s shares have lost 1.56% in the last one month, it has
advanced 1.62% in the previous three months and 20.07% on YTD
basis. The stock is trading 8.75% above its 200-day moving average.
Moreover, shares of Constellation Brands Inc. have an RSI of 50.65.
The complete research on STZ is available for free at:
https://www.EquityResearchInstitute.com/reports?keyword=STZ
Diageo PLC's stock lost 3.97%, to close the day at $114.91. The stock recorded a trading volume of
2.27 million shares, much above its three months average volume of
0.80 million shares. Over the past three months and since the
beginning of 2015, Diageo PLC's shares have gained 2.02% and 1.83%,
respectively. However, the stock has lost 5.77% in the last one
month. The company's shares are trading 0.15% above their 200-day
moving average. Additionally, Diageo PLC traded at a PE ratio of
23.74 and has an RSI of 41.88. Free in-depth research on DEO is
available at:
https://www.EquityResearchInstitute.com/reports?keyword=DEO
--
About Equity Research Institute:
Equity Research Institute ("ERI") produces regular sponsored and
non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering equities listed on NYSE and NASDAQ
and micro-cap stocks. ERI has two distinct and independent
departments. One department produces non-sponsored analyst
certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE and NASDAQ and the
other produces sponsored content (in most cases not reviewed by a
registered analyst), which typically consists of compensated
investment newsletters, articles and reports covering listed stocks
and micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
ERI has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the "CFA®"),
provides necessary guidance in preparing the document templates.
The Reviewer has reviewed and revised the content, as necessary,
based on sound investment judgment and publicly available
information which is believed to be reliable. The Reviewer and the
CFA® have not performed any independent investigations or forensic
audits to validate the information herein. Unless otherwise noted,
any content outside of this document has no association with the
Author, the Reviewer, or the CFA® (collectively referred to as the
"Production Team") in any way. The Production Team is compensated
on a fixed monthly basis and do not hold any positions of interest
in any of the securities mentioned herein.
NO WARRANTY
ERI, the Author, the Reviewer and the CFA® (collectively
referred to as the "Publishers") are not responsible for any error
which may be occasioned at the time of printing of this document or
any error, mistake or shortcoming. No liability is accepted by the
Publishers whatsoever for any direct, indirect or consequential
loss arising from the use of this document. The Publishers
expressly disclaim any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance
placed on the information in this document. Additionally, the
Publishers do not (1) guarantee the accuracy, timeliness,
completeness or correct sequencing of the information, or (2)
warrant any results from use of the information. The included
information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither ERI nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://www.equityresearchinstitute.com.
RESTRICTIONS
ERI is not available to residents of Belarus, Cuba, Canada,
Iran, North Korea, Sudan, Syria
or Somalia. Do not send email to
robottrap (at) equityresearchinstitute.com.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE www.equityresearchinstitute.com